Genentech Blasts Eli Lilly's $10M Fee Bid For Dropped IP Suit
By Dave Simpson ( May 1, 2020, 8:33 PM EDT) -- Genentech has told a California federal court that it acted in good faith when it accused Eli Lilly of infringing its patent through the sale of a psoriasis drug and therefore should not have to cover the $10 million Eli Lilly says it spent fending off the suit....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.